Previous 10 | Next 10 |
Natera (NASDAQ: NTRA ) prices its public offering of 5.714M common shares at $35/share. More news on: Natera, Inc., Healthcare stocks news, Read more ...
Natera (NASDAQ: NTRA ) initiates a $175M public offering of common stock. More news on: Natera, Inc., Healthcare stocks news, Read more ...
This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...
“We have been living and illusion that revenue and growth equals success. Even the press goes for it” -Bill Gurley 1) Invitae: The Amazon of Genetics? Invitae’s social mission is to provide affordable genetic testing for all. This has somehow earned the...
SAN CARLOS, Calif. , Oct. 3, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA ), a global leader in cell-free DNA testing, today announced it will review recent progress in its oncology business, including the positive draft local coverage decision for Signatera ™ in colo...
CAMBRIDGE, Mass. and SAN CARLOS, Calif. , Sept. 25, 2019 /PRNewswire/ -- Foundation Medicine, Inc. and Natera, Inc. (NASDAQ: NTRA) today announced a partnership to develop and commercialize personalized circulating tumor DNA (ctDNA) monitoring assays, for use by biopharmaceutical a...
LOS ANGELES , Sept. 13, 2019 /PRNewswire/ -- CBR (Cord Blood Registry), the world's largest newborn stem cell collection and storage company, today announced the asset acquisition of Natera, Inc. 's (NASDAQ: NTRA) Evercord™ newborn stem cell business. The mutually ...
SAN CARLOS, Calif. , Sept. 13, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA) and CBR (Cord Blood Registry ) today announced the acquisition by CBR, a California Cryobank Life Sciences company, and the world's largest newborn stem cell collection and storage...
SAN CARLOS, Calif. , Sept. 9, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced the publication of the largest non-invasive prenatal test (NIPT) outcomes study to date, analyzing its Panorama ® assay over a 4...
SAN CARLOS, Calif. , Sept. 4, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced it will webcast a live presentation at the Morgan Stanley 17th Annual Global Healthcare Conference at the Grand Hyatt New York on Wednesday, Se...
News, Short Squeeze, Breakout and More Instantly...
Study reports high accuracy of Signatera for surveillance of MCC patients, suggests potential to reduce frequency of surveillance imaging Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in the Journal of Clinical Oncolog...
2024-07-23 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-13 10:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...